Tyche Industries Ltd

Tyche Industries Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs 102, marking a significant decline amid a sustained downward trend. The stock has underperformed both its sector and the broader market, reflecting ongoing pressures on its financial performance and valuation metrics.

Tyche Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 10 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Tyche Industries Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.104 today, marking a significant milestone in its ongoing decline. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance and market sentiment.

Tyche Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 10 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 January 2026, providing investors with the latest insights into the stock’s performance and outlook.

Tyche Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 10 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.

Tyche Industries, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.105.2 today, marking a significant milestone in its recent price trajectory. The stock has been on a downward path for three consecutive sessions, reflecting a cumulative return of -6.64% over this period, and currently trades below all major moving averages.

Tyche Industries, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.110, marking a significant milestone in its recent price movement. The stock has experienced a sustained decline over the past two days, reflecting ongoing pressures within the company’s financial performance and market positioning.

Tyche Industries, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.111.1, marking a significant milestone in its ongoing price decline. This level reflects a continuation of the stock’s subdued performance over the past year, contrasting sharply with broader market trends.

Tyche Industries, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.111.1, marking a significant milestone in its ongoing price decline. This level reflects a continuation of the stock’s subdued performance over the past year, contrasting sharply with broader market trends.

Tyche Industries, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.111.1 today, marking a significant milestone in its ongoing price decline. This level reflects a substantial drop from its 52-week high of Rs.217, underscoring the stock’s challenging performance over the past year.

Tyche Industries, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical performance. The recent assessment highlights shifts across key analytical parameters, signalling a cautious outlook for investors.

Tyche Industries, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.111.65, marking a significant decline amid a sustained downward trend over recent sessions.

Tyche Industries, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.114, marking a significant milestone in its recent trading performance. The stock has been on a downward trajectory, reflecting a series of financial and market factors that have influenced investor sentiment and price movement.

Tyche Industries, a key player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.116.85, marking a significant price level for the stock amid a contrasting market environment.

Tyche Industries, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.116.85, marking a significant decline in its stock price amid broader market gains and sector challenges.

Tyche Industries, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.118.55 today, marking a significant price level for the stock. This decline comes despite a broadly positive market environment, with the Sensex hitting a fresh 52-week high of 85,726.26.

Tyche Industries, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.119.35 today, marking a significant milestone in its ongoing price decline. The stock has been trading below all major moving averages and has recorded a consecutive three-day fall, reflecting a challenging period for the company’s market performance.